news & events
portfolio news
21.07.17
Kala Pharmaceuticals Announces Pricing of Initial Public Offering
10.07.17
Prexton announces initiation of phase II clinical testing in Parkinson’s disease
05.07.17
Matthew Gantz Appointed CEO of Oxthera
30.06.17
Babyscripts Raises $5.7 Million to Build the Market’s Most Robust, Clinically-Validated Virtual Care Women’s Health Platform
19.06.17
Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients
15.06.17
TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn’s Disease and Ulcerative Colitis
13.06.17
TiGenix Launches Global Phase III Trial for Cx601
12.06.17
TiGenix announces final equity payment for cardiac platform acquisition
01.06.17
EUR 20 million EIB loan facility under the InnovFin programme to support medical diagnostics innovation in Spain
23.05.17
Anaconda Biomed Secures 15 Million Euro in Series A Financing Led by Ysios Capital, Innogest Capital and Omega Funds.
